Why B&G Foods Shares Are Trading Higher Today
B&G Foods (NYSE: BGS) shares are trading higher on Wednesday after the company reported better-than-expected Q4 results.
Why Is Reata Pharmaceuticals Stock Trading Higher Today?
Reata Pharmaceuticals (NASDAQ: RETA) shares are trading higher on Wednesday after the company announced the FDA approved SKYCLARYS for the treatment of Friedreich's ataxia.
Analyst Sits On Fence While Initiating Calliditas Citing ‘Near-Term Opportunity But Longer-Term Questions’
Guggenheim initiated coverage on Calliditas Therapeutics AB (NASDAQ:CALT) with a Neutral rating and an $18 price target. The analyst is impressed with…
Why Invitae Corporation Shares Are Falling Today
Invitae Corporation (NYSE: NVTA) shares are trading lower this Wednesday after the company reported fourth-quarter financial results and provided guidance for full-year 2023. The company also announced that it has signed exchange and financing agreements with a fund managed by Deerfield Management C
Guggenheim Creates Bullish Pitch For ANI Pharma On Progress With Cortrophin Launch
Guggenheim launched its coverage on ANI Pharmaceuticals Inc (NASDAQ:ANIP) with a price target of $55 and a Buy recommendation citing a “bullish view”…
Why Payoneer Global Stock Is Trading Higher Today
Payoneer Global (NASDAQ: PAYO) shares are trading higher after the company reported better-than-expected fourth-quarter EPS and issued full-year 2023 guidance above estimates.
Analyst Views Multiple Opportunities For Chinook To Thrive In Emerging Renal Markets, Sees More Than 100% Upside
Guggenheim starts coverage on Chinook Therapeutics Inc (NASDAQ:KDNY) with a Buy rating and a $43 price target, being ‘bullish’ on the immunoglobulin…
Marqeta Gets 33% Price Target Cut By Analysts, Cite Block Renewal Uncertainty
Keybanc analyst Josh Beck maintained Marqeta Inc (NASDAQ: MQ) with an Overweight and lowered
Rivian’s Positioned For Market Share Gains In Target Market, Pricier Vehicles And Legacy OEM Shift, Bullish Analyst Says
Needham analyst Chris Pierce reinstated Rivian Automotive Inc (NASDAQ:RIVN) with a Buy and a $26 price target. RIVN’s initial vehicle production guidance for…
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.